Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Current Cash

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 posts a current cash of $6.4M as of June 2026. That compares with $8.1M in the prior-year period — down 20.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Deep Medicine Acquisition - Tradeable Rights - Oct 2026's current cash was $8.1M. The latest reading is $6.4M — a 20.9% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Current Cash is one piece of Deep Medicine Acquisition - Tradeable Rights - Oct 2026's financial statement story. At $6.4M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for DMAQR's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Deep Medicine Acquisition - Tradeable Rights - Oct 2026's other metric pages and overview cover the third.